Peptide Initiative

Peptides · Peptide comparison

GHK-Cu (Copper Peptide) vs Palmitoyl Tetrapeptide-7

A naturally occurring copper peptide that acts like a master switch for your body's repair systems—boosting collagen production, accelerating wound healing, and helping your skin rebuild itself from the inside out [1][4].

Anti-inflammatory matrikine peptide that reduces IL-6-driven inflammaging for calmer, more youthful skin.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangeGHK-Cu (Copper Peptide)0.1–0.1 %Palmitoyl Tetrapeptide-73–3 %
FrequencyGHK-Cu (Copper Peptide)Once or twice daily, topicalPalmitoyl Tetrapeptide-7Once daily
AdministrationGHK-Cu (Copper Peptide)Subcutaneous injectionPalmitoyl Tetrapeptide-7Topical
Cycle lengthGHK-Cu (Copper Peptide)12 weeks, then ongoingPalmitoyl Tetrapeptide-7Ongoing/indefinite
Onset speedGHK-Cu (Copper Peptide)Moderate (1-2 weeks)Palmitoyl Tetrapeptide-7Moderate (1-2 weeks)
Evidence levelGHK-Cu (Copper Peptide)Strong preclinical (extensive animal studies)Palmitoyl Tetrapeptide-7Limited human trials

Efficacy

Benefit ratings

Skin Rejuvenation

GHK-Cu (Copper Peptide)96%
Palmitoyl Tetrapeptide-7No recorded rating

Wound Healing

GHK-Cu (Copper Peptide)94%
Palmitoyl Tetrapeptide-7No recorded rating

Tissue Regeneration

GHK-Cu (Copper Peptide)91%
Palmitoyl Tetrapeptide-7No recorded rating

Anti-Inflammatory

GHK-Cu (Copper Peptide)No recorded rating
Palmitoyl Tetrapeptide-788%

Anti-Aging

GHK-Cu (Copper Peptide)No recorded rating
Palmitoyl Tetrapeptide-782%

Skin Barrier Support

GHK-Cu (Copper Peptide)No recorded rating
Palmitoyl Tetrapeptide-780%

Technical data

Compound specifications

GHK-Cu (Copper Peptide)

Molecular formula
C14H23N6O4Cu
Molecular weight
403.93 g/mol
Half-life
Approximately 1 hour (plasma)
Bioavailability
High when injected subcutaneously; variable topically depending on formulation
CAS number
49557-75-7

Palmitoyl Tetrapeptide-7

Molecular formula
C34H62N8O7
Molecular weight
694.9 Da
Half-life
Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
Bioavailability
Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
CAS number
221227-05-0

Protocols

Dosing compared

GHK-Cu (Copper Peptide)

Topical

  • 0.1% cream (roughly 1 mg/mL)Once or twice daily to the treatment area · 12 weeks for visible results, then ongoingThis is the only GHK-Cu route with a controlled human trial behind it, and the trial was largely negative. Thirteen patients used a GHK-Cu aftercare regimen after CO2 laser resurfacing; blinded assessment found no significant improvement in redness, wrinkles or overall skin quality versus the control regimen, and only the patients' own rating separated (P = 0.04) [7]. Topical wound-healing evidence beyond that is animal — 24 rats with ischemic wounds, where the copper tripeptide gel reduced wound area faster than vehicle [4]. Concentration matters and is not standardised across products; the figures quoted for cosmetic creams come from industry reports rather than independent trials [1][2].

Subcutaneous

  • No established human doseNot established · Not establishedThere are no human studies of injected GHK-Cu by any systemic route. The GHK-Cu studies registered on ClinicalTrials.gov are topical or transdermal [13]. The 1-2 mg figures circulated for subcutaneous use trace to community practice, not to any published study, and no human toxicology exists for the copper load a systemic dose would deliver. The Pickart literature most often cited for GHK-Cu is mechanistic and wound-repair work, not injectable dosing [1][2][3].

Palmitoyl Tetrapeptide-7

Topical

  • Under 10 ppm (<0.001%) in finished productOnce or twice daily · OngoingCustomary leave-on cosmetic use is below 10 ppm of the active peptide [6]. Pal-GQPR is almost always used as a co-active alongside Pal-GHK in the Matrixyl 3000 blend rather than on its own.
  • ~3% trade solution (Matrixyl 3000 blend)Twice daily · ~2 monthsIn manufacturer clinical testing the trade-solution blend was applied twice daily for about two months [6]. The ~3% figure refers to the diluted trade solution, which contains only ppm-level active peptide.

Applications

Best suited for

GHK-Cu (Copper Peptide)

Anti-Aging Warriors
If fine lines, sagging skin, and lost elasticity are your enemies, GHK-Cu is your secret weapon. It ramps up collagen and elastin production—the two proteins responsible for keeping your skin firm and youthful [1][2]. Studies show it can tighten loose skin and improve elasticity better than many popular skincare ingredients [1][2].
Wound Healing Champions
Whether you're recovering from surgery, dealing with stubborn wounds, or healing from a cosmetic procedure, GHK-Cu accelerates the entire repair process [4]. It attracts immune cells, builds new blood vessels, and stimulates the growth factors your body needs to rebuild tissue faster and better [1].
Scar Reducers
GHK-Cu doesn't just heal wounds—it helps remodel scar tissue. By regulating how your body lays down collagen during healing, it can help scars become flatter, softer, and more like surrounding normal skin [6]. It even reduces the TGF-beta signals that lead to thick, raised scars [12].
Hair Growth Seekers
Research shows GHK-Cu can enlarge hair follicles and activate the Wnt/beta-catenin pathway—the signaling system that tells hair follicles to grow [1]. If you're noticing thinning hair or increased shedding, this peptide may help stimulate thicker, healthier growth over time.

Palmitoyl Tetrapeptide-7

Individuals with aging skin showing signs of chronic low-grade inflammation
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking to reduce UV-damage-related skin aging (photoaging)
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for synergistic peptide therapy in Matrixyl 3000 products
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

GHK-Cu (Copper Peptide)

Common

  • Injection site redness
  • Skin tingling (topical use)
  • Minor bruising
  • Mild swelling at injection site

Uncommon

  • Mild headache
  • Temporary skin purging (topical)

Serious

  • Allergic reaction

Palmitoyl Tetrapeptide-7

Common

  • Mild Redness
  • Slight Tingling
  • Mild Irritation with Other Actives
  • Dryness

Uncommon

  • Allergic Contact Dermatitis

Serious

  • Paradoxical Inflammatory Response

Research status

Safety & evidence

GHK-Cu (Copper Peptide)

Evidence level
Strong preclinical (extensive animal studies)
FDA status
Research compound
Safety overview
GHK is a peptide the body makes on its own — it turns up in human blood serum and cerebrospinal fluid, where it binds copper [5]. The peptide's original describer reports that the amount circulating falls with age, from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60 [2]. That is a description of what declines, not evidence that replacing it does anything. Almost all of the safety evidence is topical or laboratory work. The one randomized human trial of topical GHK-Cu — 13 patients using it after CO2 laser resurfacing — reported no safety problems, but also found no objective benefit over the control regimen [7]. There is no human safety data for injected GHK-Cu by any route [13]. That matters more than usual here, because the molecule carries copper: a systemic dose delivers a copper load, and no human toxicology study has measured what that load does.

Contraindications

  • Wilson's disease or copper metabolism disorders
  • Known allergy to copper or peptide components
  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Children and adolescents

Palmitoyl Tetrapeptide-7

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.

Contraindications

  • Known hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
  • Active skin infections at the application site
  • Severely compromised skin barrier with active inflammation requiring medical intervention
  • No known systemic contraindications at cosmetic concentrations

Decision guide

Which is right for you?

GHK-Cu (Copper Peptide)

Choose GHK-Cu (Copper Peptide) if…

  • Skin rejuvenation and anti-aging
  • Wound and injury recovery
  • Scar reduction
  • Hair growth support

Palmitoyl Tetrapeptide-7

Choose Palmitoyl Tetrapeptide-7 if…

  • Individuals with aging skin showing signs of chronic low-grade inflammation
  • Those seeking to reduce UV-damage-related skin aging (photoaging)
  • People looking for synergistic peptide therapy in Matrixyl 3000 products
  • Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides